Patent Assignment
Reel/Frame 069261/0553
Security Interest
Recorded: 2024-11-14
Pages: 19
Assignor
AEGIS THERAPEUTICS, LLC
Executed: 2024-11-13
Assignee
NEF ROYALTY SUB LLC
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(9)
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Compositions for Drug Administration
Application:
18/824,077 →
Compositions for Drug Administration
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Compositions for Drug Administration
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 5, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 048239/0658 →
Assignment of Assignor's Interest
Nov 11, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050976/0039 →
Assignment of Assignor's Interest
May 1, 2020
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS INC.
Reel/Frame 052548/0187 →
Assignment of Assignor's Interest
May 1, 2020
From: ARS PHARMACEUTICALS INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 052548/0243 →
Assignment of Assignor's Interest
May 1, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 052548/0236 →
Assignment of Assignor's Interest
Jun 3, 2020
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS INC.
Reel/Frame 052818/0197 →
Assignment of Assignor's Interest
Jun 3, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 052818/0213 →
Assignment of Assignor's Interest
Jun 3, 2020
From: ARS PHARMACEUTICALS INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 052818/0211 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Assignment of Assignor's Interest
Sep 14, 2021
From: ARS PHARMACEUTICALS INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 057481/0511 →
Assignment of Assignor's Interest
Sep 14, 2021
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 057481/0378 →
Assignment of Assignor's Interest
Sep 14, 2021
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS INC.
Reel/Frame 057481/0488 →
Security Interest
Jun 3, 2022
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 060096/0039 →
Assignment of Assignor's Interest
Apr 25, 2023
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS INC
Reel/Frame 063428/0221 →
Assignment of Assignor's Interest
Apr 25, 2023
From: ARS PHARMACEUTICALS INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 063428/0105 →
Assignment of Assignor's Interest
Apr 25, 2023
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 063428/0025 →
Assignment of Assignor's Interest
Jul 27, 2023
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS, INC.
Reel/Frame 064402/0733 →
Assignment of Assignor's Interest
Jul 27, 2023
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 064403/0162 →
Assignment of Assignor's Interest
Jul 27, 2023
From: ARS PHARMACEUTICALS, INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 064403/0220 →
Assignment of Assignor's Interest
Jul 27, 2023
From: ARS PHARMACEUTICALS INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 064402/0448 →
Assignment of Assignor's Interest
Jul 27, 2023
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 064402/0370 →
Assignment of Assignor's Interest
Jul 27, 2023
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS, INC.
Reel/Frame 064402/0134 →
Assignment of Assignor's Interest
Sep 4, 2024
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 068482/0895 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →